title: The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
authors.forename: M
authors.initials: M
authors.lastname: Fisher
authors.forename: D R
authors.initials: DR
authors.lastname: Tomlinson
authors.forename: R J
authors.initials: RJ
authors.lastname: Coker
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000009:adverse effects / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D017291:Clarithromycin / Q000009:adverse effects / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009164:Mycobacterium Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D015270:Mycobacterium avium-intracellulare Infection / Q000175:diagnosis / Q000188:drug therapy; D009170:Nontuberculous Mycobacteria / Q000187:drug effects / Q000302:isolation & purification; D017410:Practice Guidelines as Topic; D011718:Pyrazinamide / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D011859:Radiography; D017828:Rifabutin / Q000009:adverse effects / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000175:diagnosis / Q000188:drug therapy; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D017828:Rifabutin; D011718:Pyrazinamide; D002939:Ciprofloxacin; D000583:Amikacin; D004977:Ethambutol; D002991:Clofazimine; D017291:Clarithromycin; D011736:Pyridoxine; D007538:Isoniazid; D012293:Rifampin